Methods A comprehensive literature review of PubMed, Embase, and Elsevier databases identified 17 relevant studies published between 2013 and 2024 that investigated the role of GLP-1 receptor agonists in bone metabolism, wound healing, and orthopedic surgery
To assess heterogeneity, Chi-square and I 2 statistics were utilized, with significant heterogeneity defined as a p -value below 0.1 and an I 2 exceeding 50%
Author: Grant Demeter
Individuals with a BMI over 25 and metabolic symptoms, or a BMI over 30, may be considered for GLP-1 therapy following a medical evaluation
[DOI] [PMC free article] [PubMed] [Google Scholar] 203.Algotar A., Trofymenko S., Muramoto M., Howerter A., Kutob R